Compare Stocks

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric. It serves banking and financial services, healthcare, insurance, public sectors, manufacturing, retail, and telecom industries. The company was founded in 2005 and is headquartered in New York, New York.

RiskOn International, Inc., through its subsidiaries, owns and operates gaming platform in the United States. It also owns and operates bitnile.com metaverse platform, a social networking community that allows users to engage and purchase digital and physical products while playing 3D immersive games. The company offers virtual markets, a graphic product that changes the appearance of characters in virtual real estate, digital art, and other collectibles; sweepstakes gaming, a gaming zone for virtual and real money prizes; building private spaces, a design option that allows users to construct and customize their dream homes or private spaces; and real and virtual concerts, a concert for users. In addition, it provides fashion, electronics, and home related goods for marketplaces; organizes competitions for users, as well as enables users to interact with individuals with socialization and connectivity related products. Further, the company offers gaming options for users, sweepstakes, and social gaming experience users. The company was formerly known as BitNile Metaverse, Inc. and changed its name to RiskOn International, Inc. in November 2023. RiskOn International, Inc. was founded in 2011 and is headquartered in San Antonio, Texas.